End Of Schultz Era Looms For Teva
CEO Kåre Schultz Unlikely To Renew Contract Past November 2023, Company Confirms
Teva is expecting to have a new CEO by the end of next year, after current leader Kåre Schultz indicated that he was unlikely to renew his contract. The president and chief executive has overseen an eventful and transformative period for the Israeli firm.
